-
EP3325006
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3325006
| EP3325006 - METHODS OF TREATING CD166-EXPRESSING CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.11.2020 Database last updated on 14.06.2024 | |
| Former | Examination is in progress Status updated on 09.03.2020 | ||
| Former | Request for examination was made Status updated on 27.04.2018 | ||
| Former | The international publication has been made Status updated on 27.01.2017 | Most recent event Tooltip | 13.11.2020 | Application deemed to be withdrawn | published on 16.12.2020 [2020/51] | Applicant(s) | For all designated states The Trustees of Columbia University in the City of New York Office Of The General Counsel, 412 Low Library Mail Code 4308 535 West 116th Street New York, NY 10027 / US | [2018/22] | Inventor(s) | 01 /
SUCIU-FOCA, Nicole 120 Central Park South 19A New York, New York 10019 / US | 02 /
VLAD, George 75-23 Kessel Street Forest Hills, New York 11375 / US | 03 /
XU, Zheng 275 Fort Washington Avenue Apt. 2A New York, New York 10032 / US | [2018/22] | Representative(s) | Chapman, Paul Gilmour, et al Marks & Clerk LLP 40 Torphichen Street Edinburgh EH3 8JB / GB | [N/P] |
| Former [2018/22] | Chapman, Paul Gilmour Marks & Clerk LLP Atholl Exchange 6 Canning Street Edinburgh EH3 8EG / GB | Application number, filing date | 16828378.6 | 18.07.2016 | [2018/22] | WO2016US42833 | Priority number, date | US201562193980P | 17.07.2015 Original published format: US 201562193980 P | [2018/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017015227 | Date: | 26.01.2017 | Language: | EN | [2017/04] | Type: | A1 Application with search report | No.: | EP3325006 | Date: | 30.05.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application. | [2018/22] | Search report(s) | International search report - published on: | US | 26.01.2017 | (Supplementary) European search report - dispatched on: | EP | 01.02.2019 | Classification | IPC: | A61K39/00, A61K39/395, A61P35/00, G01N33/574, A61K38/17, C07K16/28 | [2019/10] | CPC: |
A61K38/1774 (EP,US);
A61K39/39558 (US);
A61P35/00 (EP,US);
C07K16/2803 (EP,US);
G01N33/574 (EP,US);
G01N33/57492 (EP,US);
|
| Former IPC [2018/22] | A61K39/00, A61K39/395, A61P35/00, G01N33/574 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/22] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON CD166-EXPRIMIERENDEM KREBS | [2018/22] | English: | METHODS OF TREATING CD166-EXPRESSING CANCER | [2018/22] | French: | PROCÉDÉS DE TRAITEMENT DU CANCER EXPRIMANT CD166 | [2018/22] | Entry into regional phase | 16.02.2018 | National basic fee paid | 16.02.2018 | Search fee paid | 16.02.2018 | Designation fee(s) paid | 16.02.2018 | Examination fee paid | Examination procedure | 16.02.2018 | Examination requested [2018/22] | 16.02.2018 | Date on which the examining division has become responsible | 30.08.2019 | Amendment by applicant (claims and/or description) | 12.03.2020 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2020 | Application deemed to be withdrawn, date of legal effect [2020/51] | 12.08.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/51] | Fees paid | Renewal fee | 11.07.2018 | Renewal fee patent year 03 | 15.07.2019 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2020 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO03093443 (RAVEN BIOTECHNOLOGIES INC [US], et al) [X] 1,4-6 * See claims , examples 2-4 *[I] 2,3,7-17; | [XI]WO2008117049 (AFFITECH AS [NO], et al) [X] 1,4-7,10,13 * See page 46, line 23-page 47, line 20, example 11, figure 15, claims * [I] 2,3,8,9,11,12,14-17; | [XI]WO2013033734 (UNIV COLUMBIA [US], et al) [X] 1-7,10,11,13,14 * See § " patient case selection"; claims * [I] 8,9,12,15-17 | International search | [XY]US2004048319 (MATHER JENNIE P [US], et al) [X] 10, 12-14 * entire document * [Y] 15, 16, 18, 19; | [A]US2009070890 (STASSAR MARIKE [NO]) [A] 1-22 * entire document *; | [A]US2009280109 (SUCIU-FOCA NICOLE [US], et al) [A] 1-22* entire document *; | [A]US2011151580 (DIAMANDIS ELEFTHERIOS P [CA], et al) [A] 1-22 * entire document *; | [XY]WO2013033734 (UNIV COLUMBIA [US], et al) [X] 1-7 * entire document * [Y] 15, 16, 18, 19; | [A]US2013156763 (SUCIU-FOCA NICOLE [US], et al) [A] 1-22 * entire document * |